The purpose of this study was to examine if snoring can be reduced with the use of Snorefix more than with placebo alone. Snoring noise is a symptom of upper airway resistance syndrome. The hypothesis being tested was: Snoring can be reduced with the use of Snorefix more than with placebo alone.
A repeated measure ANOVA was conducted to determine whether mean scores are statistically significant. In this research study, the group variable is not significant. The repeated measure ANOVA did not reveal a main effect of Snore Fix. The repeated measure ANOVA revealed a main effect of time. It indicated that subjects had different levels of performance on the post-test rather than the pre-test. Patients snored with a group average of 80.21 decibels before treatment with Snore Fix. Patients’ snoring level decreased to 70.38 decibels after treatment with Snore Fix.
If group differences were not the same for the treatment group and the control group, there would be a significant interaction. The interaction between group and time is significant. The repeated measure ANOVA revealed an interaction effect of group and time. Thus, the study can conclude that there is a significant difference in the snoring decibel level between those receiving the Snore Fix spray and those receiving filtered water over two points. The study can conclude the reduction of snoring noise by use of Snorefix can reduce Upper airway resistance over placebo alone.